U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The Company's lead product candidate is MyoCell, an innovative clinical therapy designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells, or cells from a patient’s body, for the purpose of improving cardiac function in chronic heart failure patients.

Type
Public
HQ
Sunrise, US
Size (employees)
3 (est)
U.S. Stem Cell is headquartered in Sunrise, US
Report incorrect company information

U.S. Stem Cell Office Locations

U.S. Stem Cell has an office in Sunrise
Sunrise, US (HQ)
212 13794 NW 4th St
Show all (1)
Report incorrect company information

U.S. Stem Cell Financials and Metrics

U.S. Stem Cell Revenue

Embed Graph
U.S. Stem Cell's revenue was reported to be $5.52 m in FY, 2017
USD

Revenue (Q2, 2018)

3.5 m

Gross profit (Q2, 2018)

2.5 m

Gross profit margin (Q2, 2018), %

69.7%

Net income (Q2, 2018)

(1.4 m)

EBIT (Q2, 2018)

(832.6 k)

Cash (30-Jun-2018)

1.7 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

96.1 k2.1 m2.2 m3.1 m5.5 m

Revenue growth, %

2040%7%41%

Cost of goods sold

30.8 k844.9 k973 k972 k1.9 m

Gross profit

65.3 k1.2 m1.2 m2.1 m3.6 m
Quarterly
USDQ1, 2018Q2, 2018

Revenue

1.7 m3.5 m

Cost of goods sold

503.8 k1.1 m

Gross profit

1.2 m2.5 m

Gross profit Margin, %

71%70%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2017

Cash

46.2 k36.7 k58.4 k986.8 k

Accounts Receivable

43 k

Inventories

70.4 k

Current Assets

66.9 k141.3 k115.6 k1.1 m
Quarterly
USDQ1, 2018Q2, 2018

Cash

1.7 m1.7 m

Accounts Receivable

75.9 k47.4 k

Inventories

76.7 k66.1 k

Current Assets

1.9 m1.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.1 m)(2.3 m)(1.6 m)(2.1 m)(3.5 m)

Depreciation and Amortization

2.2 k4.5 k5.3 k5.8 k178.7 k

Inventories

(28.1 k)

Accounts Payable

469.2 k
USDY, 2018

Financial Leverage

-0.3 x
Show all financial metrics
Report incorrect company information

U.S. Stem Cell Online and Social Media Presence

Embed Graph
Report incorrect company information

U.S. Stem Cell Company Life and Culture

Report incorrect company information